Hostname: page-component-7bb8b95d7b-s9k8s Total loading time: 0 Render date: 2024-09-22T11:20:44.647Z Has data issue: false hasContentIssue false

Melanoma-Associated Retinopathy Report of a Case and Review

Published online by Cambridge University Press:  02 December 2014

H. Bahig
Affiliation:
McGill University, Montreal, QC, Canada
F. Wein
Affiliation:
McGill University, Montreal, QC, Canada
R.F. Del Maestro
Affiliation:
McGill University, Montreal, QC, Canada
Rights & Permissions [Opens in a new window]

Abstract

Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Letters to the Editor
Copyright
Copyright © The Canadian Journal of Neurological 2011

References

1.Milam, AH, Saari, JC, Jacobson, SG, Lubinski, WP, Feun, LG, Alexander, Kr. Autoantibodies against retinal bipolar cells in cutaneous melanoma-associated retinopathy. Invest Ophthalmol Vis Sci. 1993;34(1):91100.Google ScholarPubMed
2.Chan, C, O’Day, J.Melanoma-associated retinopathy: does autoimmunity prolong survival? Clin Experiment Ophthalmol. 2001;29(4):2358.CrossRefGoogle ScholarPubMed
3.Lu, Y, Jia, L, He, S, et al.Melanoma-associated retinopathy: a paraneoplastic autoimmune complication. Arch Ophthalmol. 2009;127(12):157280.CrossRefGoogle ScholarPubMed
4.Ladewig, G, Reinhold, U, Thirkill, CE, Kerber, A, Tilgen, W, Pfohler, C.Incidence of antiretinal antibodies in melanoma: screening of 77 serum samples from 51 patients with American Joint Committee on Cancer stage I-IV. Br J Dermatol. 2005;152(5): 9318.CrossRefGoogle ScholarPubMed
5.Powell, SF, Dudek, AZ.Treatment of melanoma-associated retinopathy. Curr Treat Options Neurol. 2010;12(1):5463.CrossRefGoogle ScholarPubMed